#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Contribution of Doppler Examination in Pregnancy at Risk of Alloimune Fetus Anemia


Authors: M. Lubušký 1;  M. Procházka 1;  J. Šantavý 2;  I. Míčková 2;  Š. Machač 1;  L. Kantor 3
Authors‘ workplace: Gynekologicko-porodnická klinika LF UP a FN, Olomouc, přednosta prof. MUDr. M. Kudela, CSc. 1;  Ústav lékařské genetiky a fetální medicíny LF UP a FN, Olomouc, přednosta prof. MUDr. J. Šantavý, CSc. 2;  Novorozenecké oddělení LF UP a FN, Olomouc, primář MUDr. L. Kantor 3
Published in: Ceska Gynekol 2005; 70(1): 27-29
Category: Original Article

Overview

Objective:
To evaluate the utilisation measurements of peak systolic velocities in the middle cerebral artery (MCA-PSV) to predict fetal anemia in pregnancies complicated by alloimmune antibodies known to cause immunological hydrops.

Design:
A prospective study.

Setting:
Department of Obstetrics and Gynecology, University Hospital, Olomouc.

Methods:
In 38 pregnancies at risk for fetal anemia due to maternal red-cell alloimmunization MCA-PSV had been assessed and fetal blood sampling for measurement of hemoglobin concentration was obtained subsequently, either by cordocentesis or at delivery.

Results:
66 examinations were performed at 19–37 week’s gestation. An MCA-PSV >1.5 MoM detected 100 % of severely anemic fetuses with a hemoglobin concentration

Conclusion:
Middle cerebral artery peak systolic velocity is a highly sensitive non-invasive means for determining the degree of anemia. A Doppler interval of seven days is recommended.

Key words:
fetal anemia, middle cerebral artery peak systolic velocity, Doppler, red cell alloimmunization, intrauterine transfusion


Labels
Paediatric gynaecology Gynaecology and obstetrics Reproduction medicine

Article was published in

Czech Gynaecology

Issue 1

2005 Issue 1

Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#